Abstract: The present invention relates to pharmaceutical combinations of peroxisome proliferator-activated receptor (PPAR) agonist(s) with sterol absorption inhibitor(s), as well as to the use of these combinations for treating and/or preventing non-alcoholic fatty liver disease (NAFLD) and/or non-alcoholic steatohepatitis (NASH) and other related disorders.
| # | Name | Date |
|---|---|---|
| 1 | 202417018538-STATEMENT OF UNDERTAKING (FORM 3) [14-03-2024(online)].pdf | 2024-03-14 |
| 2 | 202417018538-POWER OF AUTHORITY [14-03-2024(online)].pdf | 2024-03-14 |
| 3 | 202417018538-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [14-03-2024(online)].pdf | 2024-03-14 |
| 4 | 202417018538-FORM 1 [14-03-2024(online)].pdf | 2024-03-14 |
| 5 | 202417018538-DRAWINGS [14-03-2024(online)].pdf | 2024-03-14 |
| 6 | 202417018538-DECLARATION OF INVENTORSHIP (FORM 5) [14-03-2024(online)].pdf | 2024-03-14 |
| 7 | 202417018538-COMPLETE SPECIFICATION [14-03-2024(online)].pdf | 2024-03-14 |
| 8 | 202417018538-Proof of Right [29-03-2024(online)].pdf | 2024-03-29 |
| 9 | 202417018538-Others-030424.pdf | 2024-04-26 |
| 10 | 202417018538-Correspondence-030424.pdf | 2024-04-26 |
| 11 | 202417018538-FORM 18 [05-08-2025(online)].pdf | 2025-08-05 |